{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:08:09Z","timestamp":1785247689410,"version":"3.55.0"},"reference-count":11,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The European Journal of Contraception & Reproductive Health Care"],"published-print":{"date-parts":[[2026,7,4]]},"DOI":"10.1080\/13625187.2026.2666796","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:40:27Z","timestamp":1777560027000},"page":"308-311","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["First report of linzagolix as bridge therapy for progesterone hypersensitivity, an ultra-rare disorder"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4734-7776","authenticated-orcid":false,"given":"Mar\u00eda Isabel","family":"Limia P\u00e9rez","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Basurto University Hospital","place":["Bilbao, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Qu\u00edlez Conde","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Basurto University Hospital","place":["Bilbao, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lois Carbajo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Basurto University Hospital","place":["Bilbao, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Juez Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Basurto University Hospital","place":["Bilbao, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9720-547X","authenticated-orcid":false,"given":"Gabirel","family":"Bell\u00f3n Barandica","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Basurto University Hospital","place":["Bilbao, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.03.003"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61838-8"},{"key":"e_1_3_5_4_1","first-page":"153","volume-title":"Recent advances in dermatology","author":"Warin AP.","year":"1977","unstructured":"Warin AP. Autoimmune progesterone dermatitis. In: Champion RH, editor. Recent advances in dermatology. Edinburgh: Churchill Livingstone; 1977. p. 153\u2013170."},{"key":"e_1_3_5_5_1","unstructured":"European Medicines Agency. Yselty (linzagolix) summary of product characteristics. [accessed Feb 2026]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/yselty."},{"issue":"5","key":"e_1_3_5_6_1","first-page":"1763","article-title":"Desensitization to progesterone in women with recurrent anaphylaxis associated with autoimmune progesterone dermatitis","volume":"7","author":"Magen E","year":"2019","unstructured":"Magen E, Feldman A, Zamir Y, et al. Desensitization to progesterone in women with recurrent anaphylaxis associated with autoimmune progesterone dermatitis. J Allergy Clin Immunol Pract. 2019;7(5):1763\u20131765.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.05.001"},{"issue":"1","key":"e_1_3_5_8_1","first-page":"1","article-title":"Successful treatment of autoimmune progesterone dermatitis with omalizumab","volume":"10","author":"Bemanian MH","year":"2014","unstructured":"Bemanian MH, Shirkhoda S, Alizadeh-Korkinejad N, et al. Successful treatment of autoimmune progesterone dermatitis with omalizumab. Allergy Asthma Clin Immunol. 2014;10(1):1\u20134.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"e_1_3_5_9_1","first-page":"48","article-title":"Autoimmune progesterone dermatitis manifested as erythema multiforme","volume":"1","author":"Halevy S","year":"2002","unstructured":"Halevy S, Cohen AD, Livni E. Autoimmune progesterone dermatitis manifested as erythema multiforme. Skinmed. 2002;1(1):48\u201350.","journal-title":"Skinmed"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810787"},{"issue":"3","key":"e_1_3_5_11_1","first-page":"327","article-title":"Autoimmune progesterone dermatitis and stomatitis","volume":"66","author":"Moghadam BK","year":"1988","unstructured":"Moghadam BK, Hersini S, Barker BF. Autoimmune progesterone dermatitis and stomatitis. Oral Surg Oral Med Oral Pathol. 1988;66(3):327\u2013332.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"e_1_3_5_12_1","first-page":"1","article-title":"The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications","volume":"17","author":"Barretta M","year":"2024","unstructured":"Barretta M, Vignali M, La Marca A, et al. The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications. Expert Opin Drug Metab Toxicol. 2024;17:1\u201313.","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["The European Journal of Contraception & Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13625187.2026.2666796","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13625187.2026.2666796","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13625187.2026.2666796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:28:50Z","timestamp":1785245330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13625187.2026.2666796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7,4]]}},"alternative-id":["10.1080\/13625187.2026.2666796"],"URL":"https:\/\/doi.org\/10.1080\/13625187.2026.2666796","relation":{},"ISSN":["1362-5187","1473-0782"],"issn-type":[{"value":"1362-5187","type":"print"},{"value":"1473-0782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iejc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iejc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}